A series of preclinical studies show that a new compound, SHP1705, targets circadian clock proteins hijacked by glioblastoma ...

A study published today in the journal Cell marks the first reported instance of generative AI designing synthetic molecules that can successfully control gene expression in healthy mammalian cells.

The medical research on human subjects has to respect the ethical principles included in the Declaration of Helsinki and the additional constraints imposed ...

No portion of this site may be copied, retransmitted, reposted, duplicated or otherwise used without the express written permission of Design And Reuse.

LONDON & BUDAPEST, Hungary--(BUSINESS WIRE)--In a landmark move, the FDA recently announced plans to phase out the requirement for animal testing ... a foundational cell model that allows ...

genetically modifiable and can be used to evaluate many genetic changes in AVM from VEGF‐induced angiogenesis to the maturation of endothelial cells in developing brain. For these reasons, mice are ...

The experiments in animal models demonstrated not only enhancement of NK cells but also that these cells can be transferred to naïve animals resulting in tumor eradication. The filed patent ...

Chimeric antigen receptor T (CAR-T) cell therapy targeting CD19 can significantly improve the long-term survival rate of patients with relapsed or refractory leukemia. However, CD19 absence or loss ...

The Jackson Laboratory, Sacramento, CA. Search for other works by this author on: ...

The work, detailed in a study published April 17 in the journal Cell Biomaterials, focuses on the H5N1 variant ... National Center for Foreign Animal Disease, which is part of the Canadian Food ...